Turn Therapeutics Inc. TTRX
Set alert
9.76 USD +0.11 +1.12%
As of Nov 3, 1:36 PM ET
9.50 Day range 10.33
2.57 52-week range 16.45
- YTD
- +147.67%
- 1 year
- +120.78%
- Open
- 9.65
- Prev close
- 9.65
- Mkt cap
- 295.93M
- Vol
- 71.96K
- Avg vol
- 108.09K
- EPS
- -0.29
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 9.50
- High
- 10.33
YTD chart
Signals (26)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| MACD: Sell Signal | Sep 25, 2026 | 1 month ago |
| RSI: Overbought | Sep 16, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 8, 2026 | 1 month ago |
| RSI: Overbought | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 23, 2026 | 3 months ago |
| RSI: Overbought | Jul 20, 2026 | 3 months ago |
| RSI: Overbought | Jul 10, 2026 | 3 months ago |
| RSI: Overbought | Jul 6, 2026 | 4 months ago |
| RSI: Overbought | Jun 30, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 25, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 18, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 15, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 8, 2026 | 4 months ago |
| RSI: Overbought | May 20, 2026 | 5 months ago |
| RSI: Overbought | May 18, 2026 | 5 months ago |
| SMA: Bullish | Apr 24, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 7, 2026 | 7 months ago |
Newest 20 of 26.
Financials — quick view
TTRX Revenue — quarterly 0
TTRX Net income — quarterly -5.85M
TTRX EPS — quarterly -0.20
News
- This Tesla Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
- This Allegion Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
- WBB Securities Upgrades Turn Therapeutics to Hold, Maintains Price Target to $10
- U.S. Bancorp | BTIG to Host Turn Therapeutics for Virtual Fireside Chat
- This Ares Management Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
- LUCID CAPITAL MARKETS Initiates Coverage On Turn Therapeutics with Buy Rating, Announces Price Target of $24
- WBB Securities Downgrades Turn Therapeutics to Sell, Announces $10 Price Target
- 12 Health Care Stocks Moving In Friday's After-Market Session
- Turn Therapeutics Appoints Former CDC Director Robert R. Redfield, M.D., as Chief Scientific Officer
- Turn Therapeutics Appoints Former CDC Director Robert R. Redfield, M.D.
Your note
Sign in to keep a note on TTRX — it syncs with the Stock Master app.